Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)

dc.contributor.authorKaracin, Cengiz
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorDemirci, Ayse
dc.contributor.authorKeskinkilic, Merve
dc.contributor.authorBaytemur, Naziyet Kose
dc.contributor.authorYilmaz, Funda
dc.contributor.authorHacibekiroglu, Ilhan
dc.date.accessioned2026-08-12T17:38:00Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1186/s12885-023-10662-3
dc.identifier.issn1471-2407
dc.identifier.issue1
dc.identifier.orcid0000-0002-9153-6921
dc.identifier.orcid0000-0003-4784-6743
dc.identifier.orcid0000-0001-9040-7266
dc.identifier.orcid0000-0002-3342-3144
dc.identifier.orcid0000-0002-5551-7731
dc.identifier.orcid0000-0002-0598-7284
dc.identifier.orcid0000-0001-6495-6712
dc.identifier.pmid36849943
dc.identifier.scopus2-s2.0-85148970683
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1186/s12885-023-10662-3
dc.identifier.urihttps://hdl.handle.net/11508/58264
dc.identifier.volume23
dc.identifier.wosWOS:000941147400001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBmc
dc.relation.ispartofBmc Cancer
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.titleEfficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)
dc.typeCorrection

Dosyalar